LENZ Therapeutics, Inc. (LENZ) Enterprise Value (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Enterprise Value for 2 consecutive years, with -$234.0 million as the latest value for Q3 2023.
- On a quarterly basis, Enterprise Value rose 19.78% to -$234.0 million in Q3 2023 year-over-year; TTM through Sep 2023 was -$234.0 million, a 19.78% increase, with the full-year FY2022 number at -$268.2 million, changed N/A from a year prior.
- Enterprise Value was -$234.0 million for Q3 2023 at LENZ Therapeutics, up from -$246.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$202.2 million in Q1 2023 to a low of -$339.2 million in Q1 2022.